Araceli Lérida‐Viso

620 citations
8 papers · 462 indexed · h-index 7
Topics
Advanced Breast Cancer Therapies (2 papers)Graphene and Nanomaterials Applications (2 papers)Cancer-related Molecular Pathways (2 papers)

In The Last Decade

Araceli Lérida‐Viso

8 papers receiving 457 citations

Peers

Araceli Lérida‐Viso
Comparison fields: 5 of 75
  • Molecular Biology 198
  • Physiology 182
  • Biomedical Engineering 110
  • Materials Chemistry 81
  • Immunology 56
Replace Irene Galiana with:
Irene Galiana Spain
Alejandra Estepa‐Fernández Spain
Xinghan Wu China
Dominika Błoniarz Poland
Zixi Wang China
Xiuying Hu China
Andrew T. Lucas United States
Nathan A. Truchan United States
Hongyan Su China
Araceli Lérida‐Viso relative to Irene Galiana Spain Irene Galiana's profile →
Citations per field
00.5×1.5×
Irene Galiana · 1×
Citations per year

Countries citing papers authored by Araceli Lérida‐Viso

Since Specialization
Citations

This map shows the geographic impact of Araceli Lérida‐Viso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Araceli Lérida‐Viso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Araceli Lérida‐Viso more than expected).

Fields of papers citing papers by Araceli Lérida‐Viso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Araceli Lérida‐Viso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Araceli Lérida‐Viso. The network helps show where Araceli Lérida‐Viso may publish in the future.

Co-authorship network of co-authors of Araceli Lérida‐Viso

This figure shows the co-authorship network connecting the top 25 collaborators of Araceli Lérida‐Viso. A scholar is included among the top collaborators of Araceli Lérida‐Viso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Araceli Lérida‐Viso. Araceli Lérida‐Viso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 1
2 134
3 25
4 56
5 14
6 8
7 15
8 209

About Araceli Lérida‐Viso

Araceli Lérida‐Viso is a scholar working on Biophysics, Physiology and Pharmacology, having authored 8 papers that have together received 462 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (2 papers), Graphene and Nanomaterials Applications (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Aging (31 citations), Physiology (182 citations) and Biomaterials (54 citations). Araceli Lérida‐Viso has collaborated with scholars based in Spain, United Kingdom and Czechia. Frequent co-authors include Ramón Martínez‐Máñez, Alejandra Estepa‐Fernández, Alba García‐Fernández, Vicente Martí‐Centelles, Juan F. Blandez, Beatriz Lozano‐Torres, Félix Sancenón, Mar Orzáez, Andrea Bernardos and David Macías. Their work appears in journals such as Advanced Drug Delivery Reviews, Nano Today and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026